Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion type Assertion NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_head.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion evidence source_evidence_literature NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion SIO_000772 16682723 NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion wasDerivedFrom befree-20150227 NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion wasGeneratedBy ECO_0000203 NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.